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ABSTRACT
Nucleotide excision repair (NER) is a major mechanism for removal of DNA
lesions induced by exposure to UV radiation in the epidermis. Recognition of damaged
DNA sites is the initial step in their repair, and requires multiprotein complexes that
contain XPC and hHR23 proteins, or their orthologues. A variety of transcription
factors are also involved in NER, including E2F1. In epidermal keratinocytes, UV
exposure induces E2F1 phosphorylation, which allows it to recruit various NER
factors to sites of DNA damage. However, the relationship between E2F1 and hHR23
proteins vis-à-vis NER has remained unexplored. We now show that E2F1 and hHR23
proteins can interact, and this interaction stabilizes E2F1, inhibiting its proteasomal
degradation. Reciprocally, E2F1 regulates hHR23A subcellular localization, recruiting
it to sites of DNA photodamage. As a result, E2F1 and hHR23A enhance DNA repair
following exposure to UV radiation, contributing to genomic stability in the epidermis.

DNA photolesions to initiate NER [4, 5]. A major role for
hHR23 proteins during NER appears to involve protection
of XPC from proteasomal degradation, thus enhancing
NER efficiency.
hHR23 proteins and their orthologues are scaffolds
necessary for normal DNA repair, but are also involved
in modulating the proteasomal degradation of a variety
of proteins [5]. They are modular proteins composed
of an N-terminal ubiquitin-like (UbL) domain and two
ubiquitin-associated domains (UBA1 and UBA2), which
bind ubiquitin or ubiquitylated proteins. Linking the
UBA1 and UBA2 regions is the XPC domain, which
mediates association of hHR23 with a variety of proteins,
including XPC [6]. Depending on the cellular context,
binding of hHR23 proteins to ubiquitylated substrates may
increase or decrease their proteasomal degradation. hHR23
can bind to and escort polyubiquitylated proteins to the
proteasome, increasing their degradation. Paradoxically,
hHR23 proteins have also been found to protect XPC and
other proteins from proteasomal degradation, possibly by
interfering with proteolysis of ubiquitylated XPC by the
proteasome [7, 8].
DNA damage triggers upregulation of several
proteins, including the E2F1 transcription factor. As a
consequence of genotoxic stress, E2F1 is phosphorylated
on Ser31 [9]. This modification interferes with E2F1

INTRODUCTION
Nonmelanoma skin carcinomas are the most
frequent malignancies in humans, accounting for about
40% of all diagnosed cancers in North America [1].
Alarming increases in their frequency in the last two
decades, particularly in young adults, are associated
with increased exposure to UV radiation, which is the
primary risk factor [2]. Two major forms of nonmelanoma
skin tumours occur, basal cell and squamous cell
carcinoma, both of which arise from the transformation of
epidermal keratinocytes [1]. Increased risk of developing
nonmelanoma skin carcinoma also occurs in individuals
affected by xeroderma pigmentosum, an autosomal
recessive genetic disorder that arises from an impaired
ability of epidermal cells to repair damaged DNA [3].
DNA damage caused by UV radiation is
characterized by the formation of cyclobutane pyrimidine
dimers (CPD) and pyrimidine (6-4) pyrimidone
photoproducts [4]. The activation of nucleotide excision
repair (NER) pathways repairs photodamaged DNA,
through processes that involve initial recognition of the
DNA distortion, followed by excision of the damaged
bases and synthesis of new DNA. In human cells,
complexes containing the DNA damage recognition
factor XPC bound to hHR23A or hHR23B associate with
www.impactjournals.com/oncotarget

26275

Oncotarget

ubiquitylation and subsequent proteasomal degradation,
and is required for E2F1 association with damaged
DNA [10]. In response to UV radiation, E2F1 associates
with damaged DNA sites, where it recruits additional
DNA repair factors, such as GCN5 [11]. In this manner,
E2F1 contributes to efficient NER. Important biological
consequences of these properties of E2F1 are the
maintenance of genomic stability and suppression of
tumour development in the epidermis [10].
The well established importance for NER of
E2F1 and hHR23, the ability of the latter to modulate
proteasomal degradation, and the stabilization of E2F1
upon DNA damage prompted us to investigate if these
two factors work together in DNA repair processes. We
now show that hHR23 proteins directly associate with
and stabilize E2F1. In turn, E2F1 can recruit hHR23A to
regions of DNA photodamage, resulting in enhanced DNA
repair.

we readily detected hHR23A fused to green fluorescent
protein (GFP) and hemagglutinin (HA) tags in V5-E2F1
immune complexes (Figure 2B). The larger molecular
mass of the GFP-tagged hHR23A species allowed us to
avoid interference of IgG heavy chains in this analysis.
We also found that endogenous E2F1 could associate with
hHR23A proteins (Figure 2C), but were unable to detect
mHR23A in E2F1 immune complexes, likely due to its
very low abundance in primary keratinocytes.
hHR23 proteins can function as scaffolds between
ubiquitylated substrates and the proteasome. To determine
if hHR23A interactions with E2F1 required ubiquitylation
of the latter, we examined if bacterially produced hHR23A
and glutathione (GST)-tagged E2F1 were able to interact.
We readily detected hHR23A in GST-E2F1 immune
complexes, indicating that interactions between these two
proteins do not require the presence of post-translational
modifications (Figure 2D). These observations do not
exclude the possibility that binding of hHR23A to E2F1
also occurs through ubiquitylated residues on the latter.

RESULTS

Modulation of hHR23A subcellular localization
by E2F1

Interaction of hHR23A and E2F1
The mammalian orthologues of yeast Rad23 (HR23)
proteins play dual roles in DNA NER and modulation of
ubiquitin-mediated protein degradation [5]. To begin to
address the role of these proteins in the epidermis, we
first assessed their expression levels in mouse tissues.
Quantitative polymerase chain reaction (qPCR) analysis
revealed the presence of transcripts encoding mHR23A
and mHR23B in the epidermis and the dermis, at
levels comparable to those found in a variety of other
tissues (Figure 1A). Further, mHR23A and mHR23B
mRNA species were also detected in primary cultured
epidermal keratinocytes, irrespective of whether they
were undifferentiated or had been induced to differentiate
(Figure 1A). mHR23A protein was detected at low levels
in mouse epidermis and in cultured keratinocytes, whereas
it was substantially more abundant in various human
epithelial cell types and mouse tissues, including the
dermis (Figure 1B, 1C).
hHR23A and mHR23A proteins participate in
NER processes through the formation of multiprotein
complexes that recognize sites of DNA damage [5]. The
ability of the E2F1 transcription factor to recognize sites
of DNA damage induced by UV radiation and to promote
NER [12] prompted us to investigate the possibility that
E2F1 and hHR23A might associate. To this end, we
exogenously expressed V5-tagged E2F1 together with
FLAG-tagged hHR23A in primary mouse keratinocytes
that had been maintained undifferentiated, or had been
induced to differentiate by 24 h of culture in medium
containing 1 mM Ca2+ (High-Ca2+ medium). When we
isolated hHR23A immune complexes, we were also able to
detect V5-tagged E2F1, irrespective of the differentiation
status of the keratinocytes (Figure 2A). Reciprocally,
www.impactjournals.com/oncotarget

Given that hHR23 proteins and their orthologues
are involved in both proteasomal degradation and DNA
repair, we next investigated the subcellular localization
of exogenously expressed hHR23A in undifferentiated
keratinocytes. We observed that hHR23A exhibited
cytoplasmic distribution in about 90% of the cells (Figure 3).
This pattern markedly differs from that observed in
transformed HeLa cells, which show nuclear concentration
of hHR23A (Figure 3).
In many cell types, including undifferentiated
keratinocytes, E2F1 is predominantly found in the nucleus,
although it exhibits nucleocytoplasmic shuttling [13]
(Figure 3). Significantly, the joint expression of hHR23A
and E2F1 resulted in the co-localization of both proteins in
the nucleus of almost all keratinocytes (Figure 3). Induction
of differentiation in keratinocytes promotes E2F1 nuclear
export and degradation [14]. Thus, it was of interest to
investigate if the presence of cytoplasmic E2F1 in these cells
was associated with loss of nuclear pools of hHR23A. We
cultured keratinocytes in medium containing either 0.12 mM
or 1.0 mM Ca2+, and found that in both culture conditions,
when E2F1 was cytoplasmic, hHR23A was also excluded
from the nucleus (Supplementary Figure S1). These
observations are consistent with the concept that E2F1 is
capable of modulating hHR23A subcellular localization and
recruitment into the nucleus, possibly mediated via complex
formation between these two proteins.

hHR23A domains involved in binding to E2F1
To begin to understand the biological significance
of E2F1 binding to hHR23A, we next undertook an
26276
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analysis of the protein domains involved in these
interactions. As a scaffold protein, hHR23A has several
functionally important domains that mediate interactions
with ubiquitin and/or various ubiquitin-unrelated proteins
[5]. To identify which of those regions are important for
E2F1 binding, we exogenously expressed several GFPand HA-tagged hHR23A deletion mutants (Figure 4A).
The use of GFP-tagged hHR23A allowed us to confirm

that the GFP moiety did not affect the ability of
hHR23A to bind E2F1 (Figure 4B), and allowed us to
efficiently express small hHR23A domains for analysis.
The N-terminal ubiquitin-like domain (UbL) in hHR23A
mediates binding to the proteasome, and is important for
protein-protein interactions. We found that deletion of
this domain (ΔUbL hHR23A) did not affect the ability
of hHR23A to interact with E2F1 (Figure 4B). hHR23A

Figure 1: Expression of mHR23 and hHR23 proteins. A. mRNA was isolated from primary undifferentiated (Undiff. KT) or

differentiated (Diff. KT) 3-day keratinocyte cultures, or from the indicated tissues harvested from 2-d-old CD-1 mice. mHR23A and
mHR23B mRNA levels were assessed by qPCR, and normalized to the abundance of Rpl16 and Rps29 transcripts. The results are expressed
as the mean + SEM (n=3), relative to mRNA abundance in undifferentiated keratinocytes, which is set to 1.0. The asterisks indicate P<0.05,
relative to abundance in undifferentiated keratinocytes (ANOVA). B, C. The abundance of mHR23A or hHR23A was determined in
protein lysates from the tissues harvested in (A) or from the indicated cultured cells. Glyceraldehyde-3-phosphatase (GAPDH) was used
to normalize for protein loading. MEK and HEK indicate, respectively, primary cultures of undifferentiated mouse and human epidermal
keratinocytes. Blot exposure times and the amount of protein on the blots (in µg) are indicated, to better illustrate differences in protein
abundance.
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has two ubiquitin-associated domains, UBA1 and UBA2,
which mediate interactions with ubiquitin moieties
conjugated to various proteins. When we exogenously

expressed two hHR23A fragments corresponding to
UBA1 or UBA2, we observed that only the former
was able to associate with E2F1 (Figure 4B). Thus, the

Figure 2: Association of hHR23A and E2F1. A, B. Primary keratinocytes were transfected with vectors encoding V5-tagged E2F1

with or without FLAG-tagged hHR23A or HA- and GFP-tagged hHR23A and cultured for 24 h after transfection in Low Ca2+ or in High
Ca2+ medium, to induce differentiation. Cell lysates were prepared and immunoprecipitated with anti-FLAG or anti-V5 antibodies, as
indicated, or an irrelevant IgG. Immune complexes were resolved by denaturing gel electrophoresis, transferred to membranes, and the blots
were probed with the indicated antibodies. Samples of lysates used for immunoprecipitation show expression levels of exogenous proteins.
γ-Tubulin was used to normalize for protein loading, and the asterisks indicate a non-specific band. C. Lysates prepared from transfected
keratinocytes as in (A, B), were immunoprecipitated with anti-E2F1 antibodies, to isolate endogenous and/or exogenous E2F1 immune
complexes. Replicate lysate samples were also analyzed to show expression levels of endogenous and exogenous proteins. D. Bacterially
produced GST, GST-E2F1, as well as His- and FLAG-tagged hHR23A (2 µg each) were used in immunoprecipitation experiments with
anti-GST or anti-His antibodies, as indicated. The immune complexes were further analyzed by immunoblot, using anti-FLAG or anti-E2F1
antibodies. The lanes labelled “Input” contain 100 ng each of the indicated recombinant proteins.
www.impactjournals.com/oncotarget
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contribution of UBA2 to hHR23A binding to E2F1 is
likely negligible, if any. In a complementary approach,
we investigated the consequences of deleting UBA1
or UBA2 in the context of the entire hHR23A protein
(hHR23A ΔUBA1 or ΔUBA2), and observed efficient
binding of these mutants to E2F1 (Figure 4B). This
suggests that, in addition to UBA1, other hHR23A
regions likely contribute to its association with E2F1.
hHR23 proteins bind the xeroderma pigmentosum
complementation group C protein (XPC) via their XPC
domain [5]. To determine if the XPC region contributes
to E2F1 binding, we expressed an hHR23A mutant

composed of only the XPC and UBA2 domains (hHR23A
XPC-UBA2). We reasoned that this mutant would
provide information on the role of the XPC domain in
this process, given our previous observation that UBA2
does not bind E2F1.We found that this hHR23A form
was still able to bind E2F1 fairly efficiently. However,
the XPC region appears to be sufficient, but not
indispensable for E2F1 binding, given that an hHR23A
mutant lacking these sequences (ΔXPC) also associates
with E2F1 (Figure 4B, Supplementary Figure S2).
Together, our observations implicate the UBA1 and XPC
domains in the association of hHR23A with E2F1.

Figure 3: Modulation of hHR23A subcellular distribution by E2F1. Primary keratinocytes or HeLa cells were transfected with

vectors encoding the indicated proteins, and 24 h later were processed for immunofluorescence microscopy using the indicated antibodies.
The histograms represent the average fraction of cells with nuclear (N) or cytoplasmic (C) protein distribution + SEM (n=4). At least 100
transfected cells per condition were scored in each experiment. The asterisks indicate P<0.05, relative to cells transfected with single
vectors (ANOVA). F-actin and DNA were visualized, respectively, with phalloidin and Hoescht 33342. Bar, 25 μm.
www.impactjournals.com/oncotarget
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Figure 4: hHR23A domains involved in E2F1 binding. A. Schematic of GFP- and HA- doubly tagged hHR23A proteins analyzed.

B. Primary keratinocytes were transfected with vectors encoding V5-tagged E2F1 and the indicated hHR23A proteins. Twenty-four hours
after transfection, cell lysates were prepared and hHR23A immune complexes were isolated and analyzed by immunoblot with the indicated
antibodies, and γ-tubulin was used to normalize for protein loading. A portion of the lysates from cells co-expressing wild type (WT)
hHR23A and V5-tagged E2F1 were also used for immunoprecipitation with an unrelated IgG control. (Continued )

www.impactjournals.com/oncotarget
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Figure 4: (Continued ) hHR23A domains involved in E2F1 binding. C. Schematic of V5-tagged E2F1 proteins analyzed. D.
Primary keratinocytes were transfected with vectors encoding wild type hHR23A and the indicated V5-tagged E2F1 proteins and analyzed
as in (B). A portion of the lysates from cells co-expressing wild type GFP-hHR23A and wild type (WT) V5-tagged E2F1 were also used for
immunoprecipitation with an unrelated IgG control.

We undertook a similar analysis to determine the
regions in E2F1 involved in binding to hHR23A. The
N-terminal domain in E2F1 mediates protein-protein
interactions, such as binding to cyclin A, and contains the
www.impactjournals.com/oncotarget

nuclear localization and export domains responsible for
nucleocytoplasmic shuttling [13]. A mutant, constitutively
cytoplasmic E2F1 protein lacking these sequences (E2F1
126-437) associated with hHR23A (Figure 4C, 4D),
26281
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indicating that nuclear localization of E2F1 is not required
for this interaction. The C-terminus in E2F1 contains the
transcriptional activation domain, and mediates proteinprotein interactions with other proteins, including those
in the retinoblastoma family (reviewed in [15]), but it
was also dispensable for hHR23A binding (Figure 4D).
Similarly, E2F1 proteins incapable of both cyclin A and
retinoblastoma binding also formed complexes with
hHR23A (Figure 4D). Of note, E2F1 contains 14 lysine
residues that can potentially be modified by ubiquitylation
and, given that the ubiquitin-binding UBA1 domain in
hHR23A participates in the interaction between these two
proteins, it is conceivable that no single region in E2F1 is
indispensable.

glycine (G76) in ubiquitin and one of the seven Lys
residues on another ubiquitin moiety. To determine whether
the stabilizing effect of hHR32A required the presence of
polyubiquitin chains on E2F1, we co-expressed V5-tagged
E2F1, FLAG-tagged hHR23A and an HA-tagged mutant
ubiquitin form lacking all lysine residues (K0). This mutant
is presumably incapable of forming polyubiquitin chains,
although it can still contribute to mono-ubiquitylation
[19]. In the absence of MG132, we found negligible E2F1
immunoreactivity in ubiquitin-K0 immunoprecipitates
(Figure 5B). Significantly, proteasomal inhibition was
associated with the presence of abundant poly-ubiquitylated
E2F1 species (Figure 5B). These observations suggest that
hHR23A may preferentially modulate the degradation
of poly-ubiquitylated E2F1, although mono-ubiquitin
modification of the latter on one or more Lys residues
likely also takes place in keratinocytes, without precluding
its proteasomal degradation.
The outcomes of hHR23 modulation of proteasomemediated proteolysis are complex. In some cases, they
deliver polyubiquitylated substrates to the proteasome
for destruction [20]. In others, they impede the
interaction of bound proteins with the proteasome, thus
suppressing their degradation [21]. To further confirm
that hHR23 negatively modulates E2F1 turnover, we used
cycloheximide chase assays to determine E2F1 half-life
(t½) in undifferentiated keratinocytes expressing wild
type or mutant hHR23A proteins (Figure 6). The t½ of
V5-E2F1 was 77±8 min, which was increased 3- and
2-fold, respectively, in the presence of similar levels of
wild type hHR23A and hHR23B. Thus, although both
hHR23 forms are able to stabilize E2F1, the effect of
hHR23A would appear to be more pronounced. Similar
to full-length hHR23A, ΔUbL GFP-hHR23A, which can
efficiently bind E2F1, increased its t½ 3-fold to 185±5
min. In contrast, expression of UBA2 GFP-hHR23A
did not significantly alter E2F1 t½, consistent with the
notion that the stabilizing effect of hHR23A requires its
association with E2F1, and that UBA2 does not associate
with this transcription factor. Although the UBA2
domain does not participate in binding to or stabilizing
E2F1, it is critical for the ability to hHR23A to escape
proteasomal degradation itself, and its deletion markedly
increases hHR23A turnover [22]. Consistent with these
characteristics, we observed that, whereas the t½ of wild
type hHR23A was > 6 h, the t ½ of ΔUBA2 GFP-hHR23A
was only about 4 h (Figure 6). Further, ΔUBA2 GFPhHR23A was without effect on E2F1 t½, suggesting that
insufficient pools of the former protein may have been
available to protect exogenous E2F1 from degradation.

Inhibition of E2F1 degradation by hHR23
proteins
E2F1 ubiquitylation includes K11-, K48- and
K63-linked polyubiquitin chains, which can promote its
proteasomal degradation [16]. To begin to characterize
the functional significance of the interactions between
hHR23 proteins and E2F1, we exogenously expressed in
keratinocytes V5-tagged E2F1 and HA-tagged wild type
ubiquitin, in the presence or absence of hHR23 proteins.
We then isolated HA-containing immune complexes
and investigated therein the presence of E2F1. This
approach allowed us to examine the effects of hHR23 on
the abundance of ubiquitylated E2F1. In the absence of
exogenous hHR23 proteins, and consistent with previous
reports [17], we detected fairly low levels of ubiquitylated
E2F1 in both undifferentiated and differentiated
keratinocytes, likely because it efficiently undergoes
proteasomal degradation (Figure 5A, 5B). The presence
of either hHR23A or hHR23B substantially increased
the abundance of ubiquitylated E2F1, irrespective of the
differentiation status of the keratinocytes. Thus, hHR23
proteins appear to protect E2F1 from degradation,
although this effect does not appear to involve interference
with E2F1 ubiquitylation per se (Figure 5A, 5B). Next,
we determined the effect of proteasomal inhibition on
modulation by hHR23A of polyubiquitylated E2F1. To
this end, we exogenously expressed V5-tagged E2F1
together with HA-tagged wild type ubiquitin and FLAGtagged hHR23A as before, and assessed the effect of
proteasomal inhibition by MG132 on the abundance
of E2F1. We observed that the robust increase in
polyubiquitylated E2F1 in the presence of hHR23A was
slightly enhanced in MG132-treated cells (Figure 5B),
indicating that exogenous expression of hHR23A does not
impair proteasomal activity but interferes with the ability
of the proteasome to target E2F1 for degradation.
The UBA domains of hHR23A exhibit maximum
affinity for chains composed of 4-6 ubiquitin residues [18].
Cellular proteins can be modified by polyubiquitin chains
linked through isopeptide bonds between the terminal
www.impactjournals.com/oncotarget

Modulation of DNA damage repair by hHR23A
and E2F1
Following DNA damage, hHR23A participates
in NER processes, whereas E2F1 is stabilized, either
26282
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Figure 5: Modulation of ubiquitylated E2F1 degradation by hHR23 proteins. A. Primary undifferentiated keratinocytes were

transfected with vectors encoding V5-tagged E2F1 and HA-tagged ubiquitin, in the presence or absence of hHR23-encoding vectors, as
indicated. The cells were cultured for 24 h in Low Ca2+ (undifferentiated keratinocytes) or High Ca2+ medium (differentiated keratinocytes)
in the absence of MG132. Cell lysates were prepared and ubiquitylated proteins were immunoprecipitated with anti-HA antibodies. HA
immune complexes were analyzed with anti-V5 antibodies, to detect ubiquitylated E2F1 in the immune complexes. The asterisk indicates a
lower mobility non-specific band. B. Primary undifferentiated keratinocytes were transfected with a vector encoding V5-tagged E2F1 and
either wild type (WT) ubiquitin, or a ubiquitin mutant lacking all Lys residues (K0), in the presence or absence of FLAG-tagged hHR23A.
Keratinocytes were treated with vehicle (dimethylsulfoxide) or MG132 (10 µM) for 6 h, and cell lysates were prepared, immunoprecipitated
with anti-HA antibodies and analyzed for the presence of ubiquitylated V5-E2F1, as in (A).

www.impactjournals.com/oncotarget
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Figure 6: Modulation of E2F1 t½ by hHR23 proteins. Primary undifferentiated keratinocytes were cotransfected with vectors

encoding V5-tagged E2F1 and the indicated FLAG- or HA-tagged hHR23 proteins. Twenty-four hours after transfection, cycloheximide
(CHX, 100 µg/ml, final) was added to the culture medium, and cell lysates were prepared at the indicated time intervals thereafter. The
lysates were analyzed by immunoblot with the indicated antibodies, and γ-tubulin was used to normalize for protein loading. The graphs
represent the mean ± SD of E2F1 levels quantified in replicate immunoblots generated from lysates prepared from three independent cell
isolates, and were used to calculate E2F1 t½ (mean±SD, n=3) in the presence of each hHR23 protein, as summarized in the chart. The
asterisks indicate P<0.05 relative to E2F1 t½ in the absence of any exogenous hHR23 protein (ANOVA).

www.impactjournals.com/oncotarget

26284

Oncotarget

promoting apoptosis or stimulating DNA repair [10].
Given that a major source of DNA damage in keratinocytes
is UV radiation, we examined the responses of these two
proteins to UV-induced DNA damage. We observed that
endogenous E2F1 levels are increased by UVB radiation or
by expression of hHR23A, and the presence of exogenous
hHR23A further increased E2F1 levels in UVB-treated
keratinocytes (Supplementary Figure S3). Next, we
determined if hHR23A subcellular localization was
regulated by DNA damage in primary keratinocytes, using
filtered UV radiation coupled with immunofluorescence
microscopy [12, 23]. Cells were irradiated with UVC
light through a filter (3-µm pore size), and nuclear regions
containing UV-induced photoproducts were identified
with an antibody specific for CPD. Because the filters
absorb about 90% of UV radiation, it was necessary to
use light in the UVC spectrum, as it induces DNA damage
more efficiently than UVB [23]. We observed that UV
treatment of keratinocytes induced cytoplasm-to-nucleus
translocation of hHR23A (Figure 7A). In the majority of
cells expressing exogenous E2F1, we observed that E2F1
was substantially enriched in nuclear areas that exhibited
CPD immunoreactivity (Figure 7A). Significantly, when
E2F1 and hHR23A were co-expressed, both proteins
concentrated in CPD-positive regions, indicating that E2F1
promotes enrichment of hHR23A at sites of UV-induced
DNA damage in primary keratinocytes (Figure 7A).
We next investigated if the increased localization of
hHR23A to DNA photolesions in the presence of E2F1
was associated with changes in DNA repair. To this end,
we transfected cells with vectors encoding hHR23A and/
or E2F1, subjected the cells to 100 J/m2 UVB radiation,
and measured decreases in CPD abundance in genomic
DNA (indicative of NER) as a function of time. Because
UVB treatment of transfected primary keratinocytes
resulted in variable proportions of transfected cell
death among different cell isolates, we conducted this
experiments on HeLa cervical carcinoma cells, in which
no such variability was observed. CPD levels in control
cells transfected with empty vector decreased by about
30%-40% of initial values 3 h after UVB treatment,
and did not decrease substantially further 6 h after UVB
treatment (Figure 7B). CPD levels in cells expressing
E2F1 or hHR23A had decreased by about 20%-25% 6 h
after UVB treatment. In contrast, in cells co-expressing
E2F1 and hHR23A, CPD levels steadily decreased by
about 40% and 60%, respectively, 3 h and 6 h following
UVB exposure. Similar results were observed in RPMI
7951 human melanoma cells (data not shown). Thus, the
joint expression of E2F1 and hHR23A accelerates CPD
removal and DNA repair following UVB damage.

Specifically, hHR23 proteins can bind E2F1 and protect
it from proteasomal degradation. In turn, E2F1 can recruit
hHR23A to the nucleus in the absence of DNA damage.
Upon photodamage, E2F1 is stabilized and is recruited to
DNA lesion sites, bringing hHR23A with it, and increasing
the efficiency of DNA repair (Figure 8).
hHR23A and its yeast orthologue Rad23 function
as shuttle proteins that deliver ubiquitylated cargo to
the proteasome for proteolysis [24]. However, hHR23A
can also associate directly with unmodified proteins.
For example, the HIV-1 protein Vpr binds to the UBA2
and XPC domains of hHR23A [6]. Similarly, our
in vitro binding assays with bacterially produced proteins
demonstrate that hHR23A also binds unmodified E2F1.
The association of hHR23A and E2F1 in vivo is likely
more complex, due to the presence of ubiquitylated E2F1
pools normally targeted for proteasomal degradation in
mammalian cells. Our domain mapping analysis clearly
indicates that the UBA2 domain in hHR23A is neither
necessary nor sufficient for E2F1 interaction. Our data
also suggest that UBA1 and XPC are important regions
involved in E2F1 binding in keratinocytes. Whereas the
XPC domain may mediate binding to unmodified E2F1
residues, UBA1 may also contact ubiquitylated E2F1. An
important area for future research will be to determine
which domains in hHR23A and E2F1 bind to each other,
independent of ubiquitin modifications.
The diversity of domains and possible modes of
interaction of hHR23A and E2F1 imply that diverse
cellular processes may be activated, depending on cell
type, differentiation status and presence of DNA-related
stresses. For example, under normal conditions, hHR23A
appears to be largely cytoplasmic in undifferentiated
keratinocytes. Significantly, E2F1 is capable of modulating
hHR23A subcellular localization in these cells, as its
exogenous expression results in nuclear concentration of
hHR23A in the absence of DNA damage in these cells.
Reciprocally, hHR23A is able to reduce E2F1 turnover
in undifferentiated keratinocytes. The ability of E2F1
to modulate hHR23A subcellular localization is further
emphasized by the observation that both E2F1 and
hHR23A remain cytoplasmic as a result of differentiation
in keratinocytes. E2F1 is indispensable in undifferentiated
keratinocytes to maintain proliferative capacity and for
their activation during epidermal repair after injury [25].
A potential role of hHR23A in these cells might be to
stabilize E2F1 to ensure maintenance of a proliferative
cell population. Further, it will be important to determine
if hHR23A also plays a role in mediating the increases in
E2F1 abundance observed in the regenerating epidermis.
Similar stabilizing roles for hHR23A have been reported
vis-à-vis p53 and ataxin-3 [8, 21].
Because of their location at the skin surface,
epidermal keratinocytes are uniquely exposed to UVrelated damage, and have evolved several protective
mechanisms, including the ability of these cells to repair

DISCUSSION
Our studies have uncovered a complex reciprocal
regulation between hHR23 proteins and E2F1.
www.impactjournals.com/oncotarget
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damaged DNA through nucleotide excision repair. The
importance of these pathways for epidermal homeostasis
is underlined by the existence of dermatological diseases
such as xeroderma pigmentosum, which is associated
with skin photosensitivity. In particular, individuals
with this disorder exhibit hypersensitivity to solar UV

light and frequent development of skin cancers [26].
Several genetic abnormalities that cause XP have been
identified, including alterations in XPC. In response to
DNA damage, various signaling proteins are recruited
to areas with altered bases. Under these conditions,
hHR23 proteins play key roles facilitating recognition

Figure 7: Increased repair of UV-induced DNA damage by E2F1 and hHR23A. A. Keratinocytes were transfected with

vectors encoding the indicated proteins, and 24 h later were subjected to UVC irradiation through 3-µm polycarbonate isopore filters, and
cultured for 2 h. The cells were processed for immunofluorescence microscopy to detect cyclobutane pyrimidine dimers (CPD), V5-tagged
E2F1 and HA-tagged hHR23A. Nuclear DNA was visualized with Hoescht 33342. Bar, 25 μm. (Continued )
www.impactjournals.com/oncotarget
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Figure 7: (Continued ) Increased repair of UV-induced DNA damage by E2F1 and hHR23A. B. HeLa cells transfected with

plasmids encoding the indicated proteins were subjected to UVB irradiation (100 J/m2). Genomic DNA was isolated at the indicated times
after UVB treatment, and analyzed for the presence of CPD as described in “Materials and Methods”. CPD levels were normalized to the
amount of dsDNA. The histograms show the fraction of normalized CPD signal remaining after 3 or 6 h, relative to CPD 0.1 h after irradiation
(set to 100%), for each transfection group. The results are expressed as the mean + SD (n=3), and the asterisks indicate P<0.05 (ANOVA).

by XPC of DNA lesion sites, contributing to the repair
of transcriptionally silent genome regions or of nontranscribed strands of transcriptionally active genes [5, 7].
Given that E2F1 is most abundant in undifferentiated basal
keratinocytes with proliferation potential [27], the cells of
origin of nonmelanoma skin carcinoma, it is conceivable
that a major role in vivo for the interaction between
hHR23 proteins and E2F1 is as a protective mechanism
against DNA damage and malignant transformation of
undifferentiated keratinocytes with proliferative potential
in the interfollicular epidermis and hair follicles.
www.impactjournals.com/oncotarget

The regulation of E2F1 in response to DNA damage
is complex, depends on the damaging agent, and occurs
through various mechanisms. The human orthologue of
E2F1 is phosphorylated by the ATM and ATR kinases
on Ser31 (Ser 29 in mouse E2F1) upon drug-induced
DNA damage, promoting its binding to 14-3-3τ, which
decreases its ubiquitylation and proteasomal degradation
[28]. Under these circumstances, stabilization of E2F1
leads to the transcriptional activation of its pro-apoptotic
targets p73 and Apaf1. E2F1 can also be acetylated on
several Lys residues in response to chemicals that cause
26287
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DNA double-strand breaks, with similar outcomes on
transcriptional activation of E2F pro-apoptotic targets
[29, 30]. Efficient DNA repair in response to UVinduced DNA damage also requires E2F1, although
different mechanisms appear to be involved. Under
those conditions, E2F1 is also phosphorylated on
Ser31 and stabilized [30, 31]. Phospho-E2F1 can
bind Topoisomerase II b-binding protein 1 (TopBP1),
decreasing p73 and Apaf1 transcription. TopBP1 also
mediates recruitment of E2F1 to DNA double-strand
breaks, where it colocalizes with BRCA1, and promotes
NER through mechanisms that appear to involve
formation of complexes containing TopBP1, E2F1 and
GCN5 [11]. Indeed, E2F1-deficient cells are deficient
in NER through mechanisms that involve impaired
recruitment of DNA repair factors, such as GCN5, to sites
of DNA damage. Further, a mouse E2F1 mutant protein
lacking Ser29 is incapable of localizing to UV-induced
sites of DNA damage, and epidermal keratinocytes
expressing this protein exhibit increased susceptibility
to UV-induced carcinogenic transformation [10]. Our
data now show a novel mechanism that contributes to
NER, through interactions between hHR23 proteins
and E2F1, and which likely involves the recruitment of
hHR23A by E2F1 to sites of DNA photodamage. Key

issues for future research are to determine if E2F1hHR23 complexes also contain XPC, and to establish
the relative importance of the E2F1-hHR23 interaction
to the overall capacity of keratinocytes to repair UVinduced DNA. This is a complex issue to address, given
that individual depletion of hHR23 proteins or E2F1
impair cellular repair capacity. The identification of E2F1
mutants incapable of binding to hHR23A may provide
answers to this question.
E2F1 is a well-established promoter of cell
proliferation, but its roles in tumour formation and
progression are complex, as it can either induce or
suppress tumourigenesis. In the context of the epidermis,
E2F1 is necessary for normal wound healing [25], and its
overexpression leads to spontaneous tumour formation,
exacerbated by the loss of p53 [32]. Paradoxically,
E2F1 also protects the epidermis from UV-induced
transformation, and cooperates with the retinoblastoma
protein, pRB, to prevent spontaneous carcinogenic
transformation of hair follicle keratinocytes through
modulation of β-catenin/Wnt pathways [10, 33]. Our
studies now provide new insights on the role of E2F1
in maintenance of genomic stability, underlining the
importance of this transcription factor in maintenance of
epidermal homeostasis.

Figure 8: Proposed model for hHR23A and E2F1 regulation of DNA repair in undifferentiated keratinocytes. A. In the

absence of DNA damage, hHR23A remains mainly localized to the cytoplasm. E2F1 is known to undergo nucleocytoplasmic shuttling
in these cells, with the equilibrium favouring nuclear concentration of this protein. Under these conditions, E2F1 turnover is promoted
by polyubiquitylation and proteasomal degradation. B. DNA photodamage induces hHR23A nuclear translocation and E2F1 recruitment
to sites of DNA lesions, with potential involvement of factors that serve as a bridge between DNA and E2F1. E2F1 can form complexes
with hHR23A at those sites, promoting DNA repair. In a coordinate fashion, E2F1 is also protected from degradation through various
mechanisms, likely including association with hHR23 proteins.
www.impactjournals.com/oncotarget
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MATERIALS AND METHODS

Cell culture and transfection

Reagents and antibodies

All animal experiments were approved by the
University of Western Ontario Animal Care Committee
(Protocol No. 2015-021), in accordance with regulations
and guidelines from the Canadian Council on Animal Care.
Primary mouse keratinocytes were isolated from 2 d-old
CD-1 mice and cultured in Ca2+-free EMEM (06-174G,
Lonza, Rockland, ME) supplemented with growth additives
and 8% fetal bovine serum (FBS) pre-treated with Chelex
resin, as described [17, 34]. Keratinocyte differentiation
was induced by culture in growth medium containing 1 mM
CaCl2 (“High-Ca2+ medium”) or with 0.12 mM CaCl2, as
noted in individual experiments, for at least 24 h. HeLa and
RPMI-7951 human melanoma cells were purchased from
the American Type Culture Collection, and cultured in HyQ
Reduced Serum DMEM (SH30565.01, Hyclone, Logan,
UT), supplemented with 4% FBS. Cells were transfected
with PEI, as described [35]. Where indicated, transfected
keratinocytes were induced to differentiate by a 24h culture
period in High Ca2+ medium, initiated 4h after transfection.
For E2F1 turnover experiments, cycloheximide (CHX, 100
µg/ml, final) was added to keratinocyte cultures 24 h after
transfection; cell lysates were prepared at timed intervals
after CHX addition and analyzed by immunoblot. For
experiments involving proteasomal inhibition, cells were
treated with MG132 (10 µM) for 6 h prior to harvesting.

Cholera toxin (100) and insulin (16634) were from
List Biological (Campbell, CA, USA) and Invitrogen
(Carlsbad, CA, USA), respectively. Polyethyleneimine
(PEI; 25 kDa linear (23966) was from Polysciences
(Warrington, PA). Chelex 100 resin was purchased from
Biorad (142-2832; Mississauga, ON, Canada). All other
reagents were purchased from Sigma (St. Louis, MO,
USA). The antibodies used were: anti-V5 (R960-25;
Invitrogen, Carlsbad, CA, or ab9113, Abcam, Cambridge,
MA), and anti-E2F1 (TA308764; OriGene, Rockville,
MD). Antibodies against cyclobutane pyrimidine dimers
(CPD) were from CosmoBio Co. (NMDND001, clone
TMD-2, Tokyo, Japan); anti-double strand (ds) DNA
(ab27156, Abcam, Cambridge, MA); anti-HA (Y-11) and
anti-Rad23A (D-6) antibodies were purchased from Santa
Cruz (Santa Cruz, CA), anti-GAPDH was from Enzo Life
Sciences (ADI CSA 335, Farmingdale, NY); anti-FLAG
M2 (F1804) and anti-γ-tubulin (T6557) were from Sigma
(St. Louis, MO). Horseradish peroxidase-conjugated
goat anti-mouse (115–035-146) and anti-rabbit (111-035144) antibodies were from Jackson Immuno Research
Laboratories (West Grove, PA). Alexa Fluor®-conjugated
phalloidin (A12379), goat anti-rabbit and goat anti-mouse
IgG were from Molecular Probes/Invitrogen (Eugene,
OR).

RNA isolation and qPCR
Total RNA was isolated from cultured cells or
from tissues harvested from 2 d-old CD-1 mice, using
RNeasy minikits (Qiagen, Louisville, KY), following the
manufacturer’s instructions. Epidermis and dermis samples
were obtained from skin treated with 8 mg/ml dispase (04
942 078 001, Roche Diagnostics, Indianapolis, IN) for 15
minutes at 37°C, as described [36]. RNA concentration and
quality were determined with an Agilent 2100 Bioanalyzer
(Agilent, Santa Clara, CA). Only samples with RNA integrity
numbers ≥8.5 were used. RNA (200 ng/sample) was reversetranscribed using SuperScript II RT (Invitrogen, Carlsbad,
CA), as per manufacturer’s protocol. qPCR reactions were
conducted on a CFX384 Real-Time PCR system (Bio-Rad)
operated by CFX Manager software (version 1.6). cDNA
samples corresponding to 20 ng of RNA were amplified
using PerfeCTa qPCR SuperMix (Quanta BioSciences,
Gaithersburg, MD) and the following primers (400 nM, final):
mHR23A forward 5’-AAGATCCGCATGGAACCTGA-3’
and reverse 5’-TGGTCACCATGACAACCACAA-3’;
mHR23B forward 5’-CTTAGGCACCATGCAGGTCA-3’
and reverse 5’-CGGAAAGGCATCTTTCCCCT-3’. The
results were normalized to the expression of the housekeeping
genes Rpl16 and Rps29, which encode ribosomal protein L16
and S29, respectively [37]. Replicate cDNA samples were
amplified for 40 cycles (98°C for 10 sec, and 58°C for 30
seconds per cycle). Primer specificity and amplicon sizes

Plasmids
The vectors encoding V5-tagged wild type and
mutant human E2F1 proteins have been described
[13, 14, 34]. Vectors encoding the FLAG- and HAtagged hHR23A, hHR23B and their truncation mutants
ΔUbL, ΔUBA2, and UBA2 [8] were generous gifts
from Dr. Christine Blattner (Institute of Toxicology
and Genetics, Karlsruher Institut für Technologie,
Germany). The vectors encoding wild type HA-tagged
ubiquitin and GST-E2F1 were kind gifts, respectively,
from Dr. David Litchfield (Western University) and
Dr. Paul Hamel (University of Toronto). The plasmids
pRK5-HA-Ubiquitin-K0 (missing all lysine residues;
Addgene plasmid 17603) and pRK5-HA-UbiquitinWT (Addgene plasmid 17608) were obtained from
Addgene (Cambridge MA), where they were deposited
by Drs. Ted Dawson and Cecile Pickart. The bacterial
expression vector encoding Flag-tagged hHR23A was
generated by polymerase chain reaction (PCR) and
cloned into the HindIII and NotI sites of pET32b-TRX.
Mammalian expression vectors encoding GFP- and HAtagged hHR23A and its deletion mutants ΔUbL, ΔUBA1,
ΔUBA2, ΔXPC, XPC-UBA2, UBA1 and UBA2 were
generated by PCR amplification and were verified by
dideoxy sequencing.
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26289

Oncotarget

were confirmed, respectively, by analysis of melt curves
conducted between 65°C and 95°C, in 0.5°C increments, and
agarose gel electrophoresis. Relative mHR23A and mHR23B
mRNA levels were calculated using the ΔΔCt method. At
least three RNA preparations obtained from three different
cell isolates were analyzed.

Volocity 6.1.1 software (Improvision-PerkinElmer,
Waltham, MA). The results shown in figures are
representative of 3-8 experiments each conducted with
independent cell isolates.

UV damage and repair assays
The co-localization of proteins to sites of UVC
radiation-induced DNA damage was conducted as
described [11, 12], with minor modifications. Keratinocyte
monolayers were rinsed once with PBS, leaving a thin
layer of buffer. A sterile 3-µm pore polycarbonate
membrane (TSTP02500, EMD Millipore Corp. Etobicoke,
Canada) was gently placed onto the cells, followed by
irradiation with 254 nm UVC light (200 J/m2), using a
Bio-Rad GS Gene Linked UV Chamber. The membrane
was removed. The cells were cultured in normal growth
medium for 2 h and processed for immunofluorescence
microscopy.
Repair of UV-induced DNA damage was assessed
as described [11], with some modifications. HeLa or
RPMI-7951 cells seeded in 10-cm culture dishes were
transfected with vectors encoding E2F1 and/or hHR23A.
Sixteen hours after transfection, the cells were trypsinized,
re-seeded in quadruplicate 35-mm culture dishes, and
cultured an additional 16-h interval to allow attachment.
Duplicate samples were then mock-irradiated or subjected
to UVB treatment (302 nm, 100 J/m2), using a UVM28 EL series 8-watt lamp (UVP, Upland, CA). At timed
intervals following UVB irradiation, genomic DNA
was purified with DNeasy Blood & Tissue kits (Qiagen,
Toronto, Canada) and denatured by boiling at 95°C for
5 minutes. Replicate 200-ng samples were spotted onto
Hybond N+ membranes (Amersham, NJ), which were
baked at 80°C for 1 h, and placed onto filter paper prewetted with 0.4 N NaOH for 20 min. The membranes
were blocked for 16 h at 4°C in 5% (w/v) non-fat milk
diluted in Tris-buffered saline supplemented with 0.2%
Tween-20 (TBST). After two TBST washes, membranes
were incubated for 2 h at 22°C with anti-CPD antibodies
(1:5000 (v/v) dilution in TBST). The membranes were
re-probed with anti-dsDNA antibodies, to normalize for
DNA content. CPD and dsDNA signals were visualized
with a VersaDoc-3000 imager (Bio-Rad Laboratories)
and quantified with Quantity One software (Bio-Rad
Laboratories). All results shown are representative of at
least three independent experiments. Statistical analyses
were conducted using ANOVA, and significance was set
at P<0.05.

Immunoblot analysis and immunoprecipitation
Cell lysates were prepared using modified RIPAlysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
0.1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium
dodecylsulphate (SDS), 1 mM Na3VO4, 5 mM NaF,
1 mM phenylmethylsulfonyl fluoride, 1 µg/ml each
aprotinin, leupeptin and pepstatin). In experiments
assessing E2F1 ubiquitylation, the lysis buffer also
contained 25 mM N-ethylmaleimide (NEM). Proteins
in lysates (30 µg/sample) were resolved by denaturing
polyacrylamide gel electrophoresis and transferred to
polyvinylidene difluoride membranes, which were probed
with antibodies indicated in individual experiments.
After antibody probing, protein signals were visualized
by treating the membranes with Amersham ECL Prime
Western Blotting Detection Reagent (GE Healthcare Life
Sciences, Mississauga, Canada). For immunoprecipitation
assays, cell lysates prepared as described above (1.5 mg
protein/sample) were incubated with antibodies indicated
in individual experiments (3 µg/sample) for 16 h at 4°C.
The immune complexes were captured by incubation
with protein A/G magnetic beads (88802, Pierce
Biotechnology/Thermo Scientific, Rockford, IL) for 1 h at
22°C, followed by 5 washes with PBS containing 0.05%
Tween-20, and elution in 1x Laemmli sample buffer for
10 min at 25°C. Immune complexes were resolved and
analysed by immunoblot, as described above. The results
shown in figures are representative of 3-8 experiments,
each conducted with independent cell isolates.

Indirect immunofluorescence microscopy
Twenty-four hours after transfection, cells were
fixed and processed for microscopy, as described
[14]. The fraction of cells with nuclear or cytoplasmic
E2F1 or hHR23A was determined from the analysis of
≥100 cells per experiment. To visualize cyclobutane
pyrimidine dimers (CPD), cells were fixed in freshly
diluted 4% paraformaldehyde in PBS, followed by
incubation in 0.2 N HCl for 30 min at 22°C, to denature
nuclear DNA. The cells were washed 5 times with PBS
and incubated with primary antibodies, as described
[14]. All photomicrographs shown are representative
of experiments conducted on duplicate samples at least
thrice, and scoring ≥ 100 transfected cells per experiment.
Images were obtained with a Leica DMIRB fluorescence
microscope equipped with an Orca-ER digital camera
(Hamamatsu Photonics, Hamamatsu City, Japan), using
www.impactjournals.com/oncotarget
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